MainboardGMP
LIVE
LIVE GMP
Watrana Rentals Ltd₹0·Crystal Crop Protection Ltd₹+45·Vedant Poly Fabs Ltd₹0·Johnsoncab Electricals Ltd₹+5·HGS (India) Ltd₹+38·Vectras Enprocon Ltd₹0·Maxwell Engineering Solutions Ltd₹+82·Antala Industries Ltd₹0·Bombay Coated & Special Steels Ltd₹+8·Carver Roboweld Ltd₹0·Ajwa Projects Ltd₹0·M.K.Sons Fine Jewels Ltd₹+3·Watrana Rentals Ltd₹0·Crystal Crop Protection Ltd₹+45·Vedant Poly Fabs Ltd₹0·Johnsoncab Electricals Ltd₹+5·HGS (India) Ltd₹+38·Vectras Enprocon Ltd₹0·Maxwell Engineering Solutions Ltd₹+82·Antala Industries Ltd₹0·Bombay Coated & Special Steels Ltd₹+8·Carver Roboweld Ltd₹0·Ajwa Projects Ltd₹0·M.K.Sons Fine Jewels Ltd₹+3·
Home › IPOs › Dipna Pharmachem Ltd.
DI
Dipna Pharmachem Ltd.
CLOSED BSE SME Fixed Price IPO Fresh Capital Dipna Pharmachem IPO GMP
GREY MARKET PREMIUM
₹ 0
No premium data
EST. LISTING PRICE
₹38
Issue Price: ₹ 38
Issue Price
₹38
Face Value
₹10
Lot Size
3,000 shares
Open Date
25 Aug 2022
Close Date
30 Aug 2022
Listing Date
08 Sep 2022
Exchange
BSE SME
Dipna Pharmachem IPO About the Company

Incorporated in 2011, Dipna Pharmachem Limited is engaged in the trading and distribution of a wide range of pharmaceutical raw materials which is also known as APIs (Active Pharmaceutical Ingredients), Excipient and chemical formulation products. The Company also started selling chemicals on a commission basis in the Financial year 2022. The company conducts business in Ahmedabad and the surrounding area of Ahmedabad.

The company's product portfolio comprises 61 AIPs and AIPs intermediates such as Cephalosporins, Cardiovascular, Anti - Bacteria, Quinolones, Veterinary, Anti - Virus, Anti - Inflammatory, Neuropsychiatry, Steroid Hormone, other etc.

The company is supplying raw materials to pharmaceutical industries and the pharmaceutical industry falls under the essential business list declared by the Government.

Competitive Strengths :

  1. Diversified Product Portfolio
  2. Experienced Promoter
  3. Quality Service
  4. High level of customer satisfaction
...read more
Dipna Pharmachem IPO Objects of the Issue
Purpose Amount (₹ Cr)
1 Working capital requirement ₹11
2 General Corporate Purpose ₹4
Dipna Pharmachem IPO Lead Managers
Interactive Financial Services Ltd.
Financial Summary Amount in Lakhs
Metric 31-Mar-20 31-Mar-21 31-Mar-22
Total Assets 1,844 2,479 3,623
Revenue 3,055 3,102 7,277
PAT 6 2 117
Net Worth 55 57 174
Reserves 51 54 170
Issue Details
Total Shares Offered
4,002,000 (100%)
Reserved for Market Maker
Up to ₹1 Cr
Net Offer to Public
Up to ₹14 Cr
Pre-Issue Shareholding
7,968,000 shares
Post-Issue Shareholding
11,970,000 shares
UPI Mandate
30 Aug 2022
IPO Analytics Dashboard
LIVE
Dipna Pharmachem IPO GMP Insights
👤
Retail Demand
Strong
💼
HNI Interest
Strong
📊
Valuation
Moderate
Dipna Pharmachem IPO GMP Strength Score
8 / 10 Strong
0–3 Weak 3–6 Moderate 6–8 Good 8–10 Strong
Dipna Pharmachem IPO Category-wise Subscription Shares offered, bid & amount
Category Sub (x) Offered Bid For
💼 NII / HNI — 1,899,000 (47%) —
👤 Retail (RII) — 1,899,000 (47%) —
📊 Market Maker — 204,000 (5%) —
Σ Total — 4,002,000 (100%) —

* Amount calculated at upper price band (₹38) ·  ** Total includes all investor categories

Subscription Overview Share allocation by investor category
💼
NII / HNI ? 1,899,000 (47%)
47%
👤
Retail (RII) ? 1,899,000 (47%)
47%
📊
Market Maker ? 204,000 (5%)
5%
Total Shares Offered 4,002,000 (100%)
Dipna Pharmachem IPO Application Sizing Minimum investment by category
👤 Retail Investors ?
Min. Lots 1
Shares / Lot 3,000
Min. Investment ₹114,000
💼 HNI Investors ?
Min. Lots 2
Min. Shares 6,000
Min. Investment ₹228,000
Dipna Pharmachem IPO Valuation — EPS & P/E Pre & post-issue metrics
Pre-Issue P/E ?
39 x
Investor Interpretation
  • Retail allocation is strong at 47% of the total offering.
  • HNI/NII demand is strong at 47%.
  • The IPO P/E of 39x reflects a moderate valuation relative to typical market ranges.

This IPO shows strong fundamentals and healthy investor demand. Research the business model and compare with sector peers before applying.

STOCK PRICE HISTORY  ·  NSE
—
Issue Price: ₹ 38  ·  Symbol: —
H —
L —
O —
Dipna Pharmachem IPO Company Info
📍 A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, Gujarat, 380055
Visit Website
Dipna Pharmachem IPO Registrar
Bigshare Services Pvt.Ltd.
Check Allotment Status
Dipna Pharmachem IPO FAQs
Dipna Pharmachem IPO has already listed. Its last recorded GMP was ₹0. GMP is only indicative and never a guarantee of listing gains.
The issue price of Dipna Pharmachem IPO is ₹38 per share. One lot has 3,000 shares, so the minimum investment is about ₹114,000. It is a Fresh Capital issue.
Dipna Pharmachem IPO opened on 25 Aug 2022 and closed on 30 Aug 2022. Shares are listed on BSE SME on 08 Sep 2022.
Incorporated in 2011, Dipna Pharmachem Limited is engaged in the trading and distribution of a wide range of pharmaceutical raw materials which is also known as APIs (Active Pharmaceutical Ingredients), Excipient and chemical formulation products.
As per the offer document, Dipna Pharmachem plans to use the IPO proceeds for: 1 Working capital requirement (₹11); 2 General Corporate Purpose (₹4).
The lead manager of Dipna Pharmachem IPO is Interactive Financial Services Ltd..
Dipna Pharmachem IPO is proposed to list on BSE SME; it is a Fixed Price IPO and the issue is a Fresh Capital.
Disclaimer

The information on mainboardgmp.com is provided for educational and informational purposes only.

We are not a Securities and Exchange Board of India (SEBI)-registered investment advisor, analyst, broker, or financial planner. The content, data, and insights on this website, including Grey Market Premium (GMP), subscription data, IPO dates, and market information, are not intended as financial advice or recommendations to buy, sell, or hold securities.

GMP and related IPO data are collected from unofficial market sources and may not reflect actual IPO listing performance or future price movements. You should not rely solely on the information provided here to make financial or investment decisions.

Investing in IPOs and securities involves risk. Always conduct your own research and consult a qualified SEBI-registered financial advisor before making investment decisions. mainboardgmp.com and its owners shall not be liable for any financial losses, trading losses, or damages arising from use of this website.

By using this website, you acknowledge and agree that you use the content at your own risk.